Announcements

Deadline:  November 07, 2022.

 

Journal is an international, peer-reviewed open - access journal on all aspects of natural sciences published monthly online.

Original articles, which provide scientific novelty and effectiveness of their outcomes and perspective implications proven with calculations, are invited for submission.

Open Access: free access for readers, with the APC being paid by authors or their institutions.

Subject area and category:  biomedicine, biomedical engineering (e.g. tissue and cellular engineering), medicine genetics, pharmaceutical development, pathogenesis, preventive medicine, and clinical medicine.

Quick reviewing: It takes 14-20 days in average to make the first decision after the submission.

Deadline:  June 30, 2022.

 

Journal is an international, peer-reviewed open - access journal on all aspects of natural sciences published monthly online.

Original articles, which provide scientific novelty and effectiveness of their outcomes and perspective implications proven with calculations, are invited for submission.

Open Access: free access for readers, with the APC being paid by authors or their institutions.

Subject area and category:  biomedicine, biomedical engineering (e.g. tissue and cellular engineering), medicine genetics, pharmaceutical development, pathogenesis, preventive medicine, and clinical medicine.

Quick reviewing: It takes 14-20 days in average to make the first decision after the submission.

Submission deadline: March 10, 2022.

 

Journal is an international, peer-reviewed open - access journal on all aspects of natural sciences published monthly online.

Original articles, which provide scientific novelty and effectiveness of their outcomes and perspective implications proven with calculations, are invited for submission.

Open Access: free access for readers, with the APC being paid by authors or their institutions.

Subject area and category:  biomedicine, biomedical engineering (e.g. tissue and cellular engineering), medicine genetics, pharmaceutical development, pathogenesis, preventive medicine, and clinical medicine.

Quick reviewing: It takes 14-20 days in average to make the first decision after the submission.